Monthly Archives: September 2024

IPO Comments to USPTO Regarding Statutory Experimental Use Exception

IPO Comments to USPTO Regarding Statutory Experimental Use Exception

By Astrid Roe|2024-09-26T17:20:12-04:00September 26th, 2024|Testimony and Comments|Comments Off

Read More

Resolution Opposing the Medication Affordability and Patent Integrity Act (S.2780)

RESOLVED, IPO opposes the Medication Affordability and Patent Integrity Act [...]

By Hannah Denny|2024-10-30T15:09:56-04:00September 22nd, 2024|Board Resolutions|Comments Off

Read More